Given the current epidemic of multidrug-resistant tuberculosis, there is an urgent need to develop new drugs to combat drug-resistant tuberculosis. Direct inhibitors of the InhA target do not require activation and thus can overcome drug resistance caused by mutations in drug-activating enzymes. In this work, the binding thermodynamic and kinetic information of InhA to its direct inhibitors, phenoxyphenol derivatives, were explored through multiple computer-aided drug design (CADD) strategies. The results show that the van der Waals interactions were the main driving force for protein–ligand binding, among which hydrophobic residues such as Tyr158, Phe149, Met199 and Ile202 have high energy contribution. The AHRR pharmacophore model generated by multiple ligands demonstrated that phenoxyphenol derivatives inhibitors can form pi–pi stacking and hydrophobic interactions with InhA target. In addition, the order of residence time predicted by random acceleration molecular dynamics was consistent with the experimental values. The intermediate states of these inhibitors could form hydrogen bonds and van der Waals interactions with surrounding residues during dissociation. Overall, the binding and dissociation mechanisms at the atomic level obtained in this work can provide important theoretical guidance for the development of InhA direct inhibitors with higher activity and proper residence time.
Protein filaments are ubiquitous in nature and have diverse biological functions. Cryo-electron microscopy (cryo-EM) enables the determination of atomic structures, even from native samples, and is capable of identifying previously unknown filament species through high-resolution cryo-EM maps. In this study, we determine the structure of an unreported filament species from a cryo-EM dataset collected from Bacillus amyloiquefaciens biofilms. These filaments are composed of GerQ, a spore coat protein known to be involved in Bacillus spore germination. GerQ assembles into a structurally stable architecture consisting of rings containing nine subunits, which stacks to form filaments. Molecular dockings and model predictions suggest that this nine-subunit structure is suitable for binding CwlJ, a protein recruited by GerQ and essential for Ca2+-DPA induced spore germination. While the assembly state of GerQ within the spores and the direct interaction between GerQ and CwlJ have yet to be validated through further experiments, our findings provide valuable insights into the self-assembly of GerQ and enhance our understanding of its role in spore germination.
The aggregation of crystallin proteins in human lens is the primary cause of cataracts, a disease that leads to blindness of tens of millions of people worldwide. Understanding the molecular architectures of these aggregated crystallin proteins can facilitate the development of therapeutic drugs to treat cataract without surgery. In this study, we prepared two types of crystallin fibrils, thick and thin, using recombinant human αA-crystallin harboring the disease-associated R116C mutation under neutral and acidic conditions, respectively. The structure of the thin fibrils was determined via cryo-EM at a resolution of 3.7 Å, whereas the thick fibrils appeared unsuitable for cryo-EM structure determination. Structure analysis suggests that the thin fibrils adopt a three-layered structure stabilized by extensive steric zipper interactions. The observation of aspartate and glutamate ladders stacking along the fibril axis is consistent with the preference for an acidic environment of the thin fibrils. Disease mutations on Arg49 and Arg54 appear to facilitate the fibril structure, suggesting the potential disease relevance of these fibrils. Taken together, our study provides the first near-atomic resolution structure of aggregated crystallin and may facilitate the future studies on the mechanism and therapeutic of cataracts.
Glycoprotein 2 (GP2) and Uromodulin (UMOD) are considered as paralogs that share high sequence similarity and have similar antibacterial functions. UMOD are abundant as filaments in the urinary tract, and a high-mannose N-glycosylation site located on the N-terminal region protruding from UMOD filament core (referred to as branch) acts as an adhesion antagonist against pathogenic bacterial infections. The antibacterial function of UMOD can be eliminated by proteases, as the UMOD branch is susceptible to proteolytic activity. GP2 is expressed in the pancreas and secreted into the digestive tract. Whether GP2 executes its function in filament form and how it remains functional in the protease-enriched digestive tract is unclear. In this study, we extract GP2 filaments from surgically excised human pancreas and determined their cryo-EM structure. Our structure analysis unveiled that GP2 forms filaments with its ZP modules, composing the ZPN and ZPC domains along with a linker that connects these two domains. The N-terminal region (branch) of GP2 does not constitute the filament core and appears flexible in the cryo-EM structure. Our biochemical experiments suggested that although the GP2 branch is also protease-susceptible, additional high-mannose N-glycans were identified on the protease-resistant GP2 filament core. Consequently, the branch-free GP2 filaments retain their binding ability to the bacterial adhesin FimH, ensuring GP2’s antibacterial function unaffected in the proteolytic environment. Our study provides the first experimental evidence of GP2 filament formation and reveals the molecular mechanisms underlying GP2’s adaptation to a different environment compared to UMOD.
RegIIIα is an antibacterial protein primarily operating in the digestive tract to defend against bacterial infection through direct bactericidal activity. A previous study proposed that RegIIIα forms hexameric pores on the membrane of Gram-positive bacteria, leading to cell lysis. These RegIIIα hexamers can further assemble into filaments, diminishing RegIIIα activity. However, the high-resolution structure of RegIIIα assembly remains elusive, impeding the comprehension of the molecular mechanisms underlying RegIIIα function. In this study, we determined the cryo-electron microscopy (cryo-EM) structure of RegIIIα filaments formed in vitro at a resolution of 2.2 Å. Our structure reveals a similar subunit arrangement but a distinct subunit orientation compared to the previously reported low-resolution model of RegIIIα filaments. Through structural analysis and biochemical assays, we identified two essential interfaces for RegIIIα assembly, offered a potential explanation for the necessity of lipids in RegIIIα assembly, and elucidated the inhibitory mechanism of the pro-segment of RegIIIα. Collectively, our study presents the first near-atomic structure of filaments formed by C-tyle lectin containing proteins, providing structural insights into RegIIIα assembly that are closely related to its physiological functions and regulations.
The deposition of β-amyloid (Aβ) in the brains is considered a key factor in the pathogenesis of Alzheimer’s Diseases (AD), as supported by the link between Aβ mutations and familiar AD (FAD). More than ten Aβ mutations have been identified as causative for FAD, yet the molecular architectures of fibrils formed by most of these mutants remain elusive. In this study, we report the cryo-EM structures of Aβ fibrils formed by the Flemish (A21G) and Italian (E22K) mutants at resolutions of 3.1 - 4.0 Å. Aβ42A21G fibrils exhibit four morphologies comprising two distinct conformations, whereas Aβ42 E22K fibrils display a single morphology with a unique fold stabilized by salt bridges involving Lys22. Despite these structural differences, the oligomeric forms of both mutants are recognized by the natural neuronal Aβ receptor LilrB2. Our findings provide molecular insights into how disease-relevant mutations affect Aβ aggregation, with potential implications for the development of therapeutics and diagnostics for corresponding FAD subtypes.